HMT’s credentials
The HMT team has a range of experience across the healthcare sector including equity and debt raises and advice to private and institutional vendors and acquirers in the following sub-sectors
M&A activity in the UK health-tech sector remains strong, driven by digital transformation, increasing healthcare demand and the need for more efficient models of care. Strategic buyers and private equity investors continue to target businesses across digital health, healthcare software, diagnostics and data-driven solutions. Companies with proprietary technology, recurring revenues, scalable platforms and strong positions in specialist healthcare markets are particularly attractive, while the growing adoption of AI and automation is creating further opportunities for innovation, consolidation and investment across the sector.
M&A activity in the UK research and medical sector remains active, supported by demand for innovation, specialist expertise and improved healthcare outcomes. Strategic buyers and private equity investors continue to target businesses across medical research, diagnostics, clinical services and specialist healthcare products. Companies with differentiated intellectual property, strong technical capabilities, recurring revenues and exposure to growing areas of healthcare demand are particularly attractive, while continued investment in research and development is creating further opportunities for consolidation and growth.
Healthcare is a broad sector which encompasses everything from domiciliary care providers to private health and aesthetic care clinics, from contract research organisations to gene editing companies and from Healthcare IT (HCIT) to medical instrumentation.
With a vast global market to address, the sector is highly regulated, creating demanding barriers to entry. At the same time the purchasing cycle can be frustratingly long and the route to market, particularly in the public sector, is a real challenge for new technologies and business offerings. As a result of this, healthcare businesses often require multiple rounds of investment and/or M&A to realise their potential.
While the press tends to focus on mega pharmaceutical and biotechnology-led transactions, the services focussed mid-market is also highly active, with private equity investors and acquirers keen to identify the likely winners in a well-spread field of runners.
It is critical that businesses understand their specific place in a complex industry and can articulate the factors which will drive their success, be they intellectual property based or delivery led.
Because of the buying environment for healthcare, the time to market can be elongated and investors and acquirers will look for evidence of market engagement. Identifying the right funder or acquirer to ensure “fit” is key to funding or M&A success and HMT’s experience of the funding market and the global reach which ICFG affords us helps us match businesses in the sector with their perfect partner.
Why HMT
Passionate
We are passionate about delivering an optimal outcome for our clients and helping them achieve their personal objectives. We understand entrepreneurial businesses because we are one.
Our Deals
Personal
Partners are supported by high-calibre professional staff who share our core values of enthusiasm, energy, entrepreneurialism and empathy to our client's objectives.
Our Team
Proven
Our Partners have unparalleled deal experience in the mid-market and are supported by a team of dedicated deal-doers with specialist capabilities and experience.
About Us
Connected
We have an extensive network of acquisitive corporates, institutional investors and debt providers both in the UK and internationally through our membership of our global network Cognos.
Our Network
